Burling Wealth Partners LLC Buys Shares of 1,119 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Burling Wealth Partners LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,119 shares of the medical equipment provider's stock, valued at approximately $584,000.

Other large investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $2,401,493,000. Proficio Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after buying an additional 948,902 shares during the period. Capital Research Global Investors grew its holdings in shares of Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth about $313,769,000. Finally, Wilmington Savings Fund Society FSB boosted its position in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently commented on ISRG. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday. UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Finally, Barclays dropped their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded up $6.46 during midday trading on Friday, reaching $514.59. The stock had a trading volume of 2,015,889 shares, compared to its average volume of 1,617,024. The company's 50 day moving average price is $511.92 and its 200 day moving average price is $533.05. Intuitive Surgical, Inc. has a twelve month low of $367.39 and a twelve month high of $616.00. The firm has a market cap of $183.29 billion, a price-to-earnings ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,454 shares of company stock valued at $18,564,027 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.